10 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we reviewed Jim Simons' investment strategy, historical performance, and family office portfolio.
Alector Inc. (ALEC)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 4,994,970 | $113,985 | +18% | 3.96% |
| 2. | Casdin Capital Eli Casdin | 1,650,000 | $37,653 | 0.93% | |
| 3. | Deerfield Management James E. Flynn | 1,055,192 | $24,079 | 0.46% | |
| 4. | Euclidean Capital Jim Simons | 980,894 | $22,384 | 10.88% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 312,561 | $7,132 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 20,000 | Director | 44,621 | 2020-02-03 | Filing | |
| $19.00 | 203,200 | Large Shareholder, Director | 203,200 | 2019-02-11 | Filing | |
| $19.00 | 50,561 | Large Shareholder, Director | 2,455,853 | 2019-02-11 | Filing | |
| $19.00 | 157,939 | Large Shareholder, Director | 10,434,976 | 2019-02-11 | Filing | |
| $19.00 | 203,200 | Large Shareholder, Director | 203,200 | 2019-02-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.09 | 250 | Officer | 528,691 | 2021-12-01 | Filing | |
| $25.00 | 55,000 | Officer, Director | 1,972,875 | 2021-11-11 | Filing | |
| $25.00 | 55,000 | Officer, Director | 2,027,875 | 2021-11-10 | Filing | |
| $25.00 | 15,000 | Officer, Director | 652,500 | 2021-11-09 | Filing | |
| $25.00 | 15,000 | Officer, Director | 652,500 | 2021-11-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 57,695 | $1,316,600 | 0% | |
| 2. | 28,162 | $642,657 | 0% | |
| 3. | 5,270,814 | $120,279 | 0% | |
| 4. | 5,077,433 | $115,867 | 0% | |
| 5. | 5,000,918 | $114,121 | 0.21% |
News See All
5 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
Is Alector (ALEC) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
25 Easiest Trivia Questions For Seniors With Dementia
Dementia is a terrible disease, but these 25 easiest trivia questions for seniors with dementia will perhaps provide a bright spark in the day for anyone afflicted with the illness.
Hedge Funds Are Piling Into Alector, Inc. (ALEC)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Keep Buying Alector, Inc. (ALEC)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Hedge Funds Have Never Been More Bullish On Alector, Inc. (ALEC)
Is Alector, Inc. (NASDAQ:ALEC) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it.
Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...
Billionaire Hedge Funds
